Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area pi3k akt signaling gsk'

Search results for: 'research area pi3k akt signaling gsk'

Items 11-20 of 55

Page
per page
  1. Wnt-C59
    A8685 Wnt-C59
     2 Citation
    Target: PORCN
    Summary: PORCN inhibitor,highly potent and selective
      .95 mg/mL
      insoluble in H2O; ≥18
  2. FH535
    A3413 FH535
    Summary: Wnt/B-catenin inhibitor
      ≥36.1 mg/mL
  3. ICG 001
    A8217 ICG 001
     1 Citation
    Summary: Wnt/β-catenin pathway inhibitor
      ≥27.43 mg/mL
  4. LY2940680
    A8651 LY2940680
    Target: Smoothened receptor
    Summary: Hedgehog/SMO antagonist,inhibits Hh signaling
  5. JW 55
    A4529 JW 55
    Summary: PARP domain inhibitor
      insoluble in H2O; ≥19.25 mg/mL
  6. XAV-939
    A1877 XAV-939
     1 Citation
    Target: TNKS
    Summary: Tankyrase 1/2 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥15.62 mg/mL
  7. IWP-2
    A3512 IWP-2
     2 Citation
    Summary: Wnt production inhibitor,PORCN inhibitor
      ≥23.35 mg/mL
  8. Salinomycin
    A3785 Salinomycin
    Target: Antibiotic
    Summary: Polyether ionophore antibiotic;anti-cancer
  9. TWS119
    B1540 TWS119
     1 Citation
    Summary: GSK-3β inhibitor
      insoluble in H2O; insoluble in EtOH; ≥15.9 mg/mL
  10. CHIR-98014
    A8395 CHIR-98014
    Target: GSK-3
    Summary: GSK-3β inhibitor,selective and ATP-competitive
      insoluble in H2O; insoluble in EtOH; ≥8.1 mg/mL

Items 11-20 of 55

Page
per page